We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.29%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$139M
AUM Growth
-$1.6M
(-1.1%)
Cap. Flow
+$2.51M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
29.02%
Holding
165
New
8
Increased
106
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTM
ZoomInfo Technologies
GTM
|
+$516K |
| 2 |
DoubleVerify
DV
|
+$495K |
| 3 |
AAN
The Aaron's Company Inc
AAN
|
+$430K |
| 4 |
Emergent Biosolutions
EBS
|
+$390K |
| 5 |
MongoDB
MDB
|
+$356K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$1.01M |
| 2 |
Dynatrace
DT
|
+$887K |
| 3 |
NTUS
Natus Medical Inc
NTUS
|
+$418K |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$334K |
| 5 |
Ascendis Pharma A/S
ASND
|
+$313K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.9% |
| 2 | Healthcare | 14.62% |
| 3 | Industrials | 12.21% |
| 4 | Real Estate | 6.65% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
KLA
KLAC
$275B
| $231K | 0.17% |
7,630
-550
| -7% | -$19.1K |
|
|
PDCO
127
DELISTED
Patterson Companies, Inc.
PDCO
| $228K | 0.16% |
9,503
+381
| +4% | +$10.9K |
|
128
Digi International
DGII
$2.52B
| $219K | 0.16% |
+6,334
| New | +$197K |
|
129
IDEX
IEX
$16.5B
| $213K | 0.15% |
1,067
-62
| -5% | -$12.5K |
|
130
Baxter International
BAX
$11.6B
| $205K | 0.15% |
+3,805
| New | +$229K |
|
131
Alexandria Real Estate Equities
ARE
$8.88B
| $202K | 0.15% |
1,443
-247
| -15% | -$37.9K |
|
132
Neogen
NEOG
$2.05B
| $192K | 0.14% |
+13,714
| New | +$276K |
|
133
Stratasys
SSYS
$697M
| $181K | 0.13% |
12,583
+457
| +4% | +$8.14K |
|
134
Talphera
TLPH
$70.1M
| $166K | 0.12% |
39,708
+1,350
| +4% | +$7.07K |
|
135
Cogent Biosciences
COGT
$6.79B
| $164K | 0.12% |
11,012
-5,298
| -32% | -$72.6K |
|
136
Mistras Group
MG
$492M
| $162K | 0.12% |
36,311
+1,158
| +3% | +$6.56K |
|
|
LL
137
DELISTED
LL Flooring Holdings, Inc.
LL
| $151K | 0.11% |
21,830
+687
| +3% | +$6.17K |
|
138
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $142K | 0.1% |
1,786
+66
| +4% | +$5.56K |
|
139
Annexon
ANNX
$855M
| $133K | 0.1% |
+21,581
| New | +$117K |
|
140
Immunovant
IMVT
$8.09B
| $130K | 0.09% |
23,245
+763
| +3% | +$3.73K |
|
141
Lifetime Brands
LCUT
$199M
| $123K | 0.09% |
18,196
+656
| +4% | +$6.21K |
|
142
Tandy Leather Factory
TLF
$19.5M
| $118K | 0.08% |
+32,395
| New | +$139K |
|
143
Zymeworks
ZYME
$1.68B
| $105K | 0.08% |
16,998
-1,142
| -6% | -$6.88K |
|
|
LCI
144
DELISTED
Lannett Company, Inc.
LCI
| $93K | 0.07% |
51,699
+1,720
| +3% | +$3.77K |
|
|
GIFI
145
DELISTED
Gulf Island Fabrication
GIFI
| $86K | 0.06% |
20,673
+648
| +3% | +$2.41K |
|
|
DHC
146
Diversified Healthcare Trust
DHC
$2.26B
| $81K | 0.06% |
82,003
+3,306
| +4% | +$5.3K |
|
|
TRML
147
DELISTED
Tourmaline Bio
TRML
| $81K | 0.06% |
3,072
+1,904
| +163% | +$69.4K |
|
|
NBRV
148
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $54K | 0.04% |
25,891
+24,142
| +1,380% | +$102K |
|
149
Pluri
PLUR
$19.2M
| $38K | 0.03% |
6,041
+188
| +3% | +$1.5K |
|
150
Roivant Sciences
ROIV
$25.2B
| $37K | 0.03% |
11,445
-2,755
| -19% | -$10.7K |
|
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Values First Advisors held 165 positions worth $139M, down 1.1% from $141M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Values First Advisors's Q3 2022 filing shows 8 new, 106 increased, 38 reduced and 9 closed positions. Its largest new stake was DoubleVerify: 19,213 shares worth $525K. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $1.01M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.
- Values First Advisors's largest Q3 2022 buy was DoubleVerify: 19,213 shares worth $525K.
- Values First Advisors added most to ZoomInfo Technologies in Q3 2022, an estimated $516K increase.
- Values First Advisors's biggest Q3 2022 reduction was Ascendis Pharma A/S, cutting an estimated $313K.
- Values First Advisors fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $1.01M.
- Values First Advisors's ten largest holdings make up 29% of its $139M portfolio in Q3 2022.
- Values First Advisors opened 8 new positions and closed 9 in Q3 2022.
- Values First Advisors's portfolio value fell 1.1% quarter-over-quarter to $139M.
Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.